TNRC6B and attention deficit-hyperactivity disorder: Speech delay was documented in 94% of individuals with pathogenic TNRC6B variants, followed by other forms of developmental delay, intellectual disability, ASD, ADHD, behavioral abnormalities, musculoskeletal abnormalities, and dysmorphic features (Granadillo et al. 2020).